By Dr. Sanchari Sinha Dutta, Ph.D. A detailed genomic investigation of a Denver Zoo outbreak shows how SARS-CoV-2 can rapidly diversify and adapt after crossing species, offering a rare real-world ...

Researchers at the Federal University of São Paulo (UNIFESP) in Brazil have discovered that SARS-CoV-2, the virus that causes COVID-19, uses a sophisticated tactic to evade the human body's defense ...

On 17 December 2025, the World Health Organization (WHO) announced the prequalification of two rapid antigen diagnostic tests ...

Patient-centered care in MM involves aligning treatment with evolving quality-of-life priorities, especially during remission.

Learn more about whether Twist Bioscience Corporation or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Common cold, flu and COVID-19 symptoms and cases can spike during the year-ending holidays, according to Johns Hopkins winter ...

France has confirmed its first cases of the deadly Middle East Respiratory Syndrome in over a decade, with the WHO reporting ...

The WHO estimates that in 2019, bacterial antimicrobial resistance directly caused 1.27 million deaths and contributed to ...

Research finds brain changes in long COVID patients and recovered people compared to never-infected people. What does this ...

DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID versus placebo, at three months, from a single ...

NEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and mRESVIA (Respiratory Syncytial Virus Vaccine)mNEXSPIKE will be available in the ...